» Authors » Sarah L Elkin

Sarah L Elkin

Explore the profile of Sarah L Elkin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 802
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar K, Ratnakumar R, Collin S, Berrocal-Almanza L, Ricci P, Al-Zubaidy M, et al.
Clin Med (Lond) . 2023 Sep; 23(5):467-477. PMID: 37775167
Long-term pulmonary sequelae of Coronavirus 2019 (COVID-19) remain unclear. Thus, we aimed to establish post-COVID-19 temporal changes in chest computed tomography (CT) features of pulmonary fibrosis and to investigate associations...
2.
Kumar K, Ratnakumar P, Ricci P, Al-Zubaidy M, Srikanthan K, Agrawal S, et al.
Future Healthc J . 2022 Dec; 9(3):335-342. PMID: 36561827
In response to the first COVID-19 surge in 2020, secondary care outpatient services were rapidly reconfigured to provide specialist review for disease sequelae. At our institution, comprising hospitals across three...
3.
Baker J, Fenwick P, Koss C, Owles H, Elkin S, Fine J, et al.
JCI Insight . 2022 Jun; 7(15). PMID: 35763349
Current treatments fail to modify the underlying pathophysiology and disease progression of chronic obstructive pulmonary disease (COPD), necessitating alternative therapies. Here, we show that COPD subjects have increased IL-36γ and...
4.
Kumar K, Groom K, Martin L, Russell G, Elkin S
Postgrad Med J . 2021 Aug; 98(1159):328-330. PMID: 34344700
The COVID-19 pandemic has had a significant impact on postgraduate medical training across all specialties. Although some traditional learning opportunities have been curtailed, there have been numerous examples of highly...
5.
Bloom C, Ramsey H, Alter M, Lakhani S, Wong E, Hickman K, et al.
J Asthma Allergy . 2020 Oct; 13:429-437. PMID: 33116651
Background: Guidelines recommend that asthma treatment should be stepped down to the minimally effective dose that achieves symptom control to prevent medication side effects and reduce unnecessary costs. Little is...
6.
Kumar K, Mak V, Groom K, Razak Y, Brown J, Hyde T, et al.
Future Healthc J . 2020 Oct; 7(3):e88-e92. PMID: 33094266
Integration of primary and secondary care for the management of respiratory disease is a long-held ambition. Here, we describe how respiratory specialists at a large NHS trust, working with primary...
7.
Gupta A, Jayes L, Holmes S, Sahota O, Canavan M, Elkin S, et al.
Int J Chron Obstruct Pulmon Dis . 2020 Jul; 15:1377-1390. PMID: 32606647
Introduction: Osteoporosis and bone fractures are common in chronic obstructive pulmonary disease (COPD) and contribute significantly to morbidity and mortality. Current national guidance on COPD management recommends addressing bone health...
8.
Ritchie A, Brill S, Vlies B, Finney L, Allinson J, Alves-Moreira L, et al.
Am J Respir Crit Care Med . 2020 Apr; 202(4):549-557. PMID: 32267724
Chronic obstructive pulmonary disease (COPD) exacerbations are prone to nonrecovery, but there are no data about the effectiveness of retreatment for these prolonged events. We examined whether further therapy with...
9.
Finney L, Padmanaban V, Todd S, Ahmed N, Elkin S, Mallia P
ERJ Open Res . 2019 Jun; 5(2). PMID: 31249841
Rationale: Exacerbations of chronic obstructive pulmonary disease (COPD) and pneumonia are two of the most common reasons for acute hospital admissions. Acute exacerbations and pneumonia present with similar symptoms in...
10.
Calderazzo M, Trujillo-Torralbo M, Finney L, Singanayagam A, Bakhsoliani E, Padmanaban V, et al.
Int J Chron Obstruct Pulmon Dis . 2019 May; 14:823-832. PMID: 31114182
COPD patients often do not report acute exacerbations to healthcare providers - unreported exacerbations. It is not known whether variances in symptoms, airway obstruction, aetiology and inflammatory responses account for...